All News

The FDA recently approved azelaic acid (Finacea, Berlex Laboratories) 15.0% gel for the topical treatment of the inflammatory papules and pustules characteristic of mild-to-moderate rosacea. Finacea should be available in pharmacies during the first quarter of 2003.

The Massachusetts attorney general blasted pharmcies for passing a new $1.30 per Rx tax onto consumers. The tax was imposed to raise $36 million for the state Medicaid program but the law doesn't spell out whether pharmacies can charge consumers to the levy.

"It's Illegal" is a new campaign to make US consumers and the media aware that importing Rx drugs is unlawful has been launched by the National Community Pharmacists Association

Community pharmacists are angry that the government began soliciting sponsors for the proposed Medicare-endorsed discount Rx drug cards before a federal judge had issued a final ruling on the legality of the proposal.

Forteo (teriparatide) treats osteoporosis in men,and women who have gone through menopause.

Patients with rheumatoid arthritis (RA) now have a first-of-its-kind therapeutic option that is safe, convenient, and effective. The FDA recently approved adalimumab (Humira, Abbott Laboratories) for reducing the signs and symptoms and inhibiting the progression of structural damage in adult patients with moderately to severely active RA who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). The approval of adalimumab comes just nine months after regulatory submission. Adalimumab will be available in pharmacies by mid-January.

Keeping patients on long term therapy requires multifaceted interventions but even complex approaches don't lead to big improvements in adherence or improved outcomes, according to researchers from the McMaster University Faculty of Health Sciences in Ontario.

The FDA recently approved teriparatide (rDNA origin) injection [Forteo, Eli Lilly], a recombinant form of human parathyroid hormone, for the treatment of postmenopausal women with osteoporosis who are at increased risk for fracture. Teriparatide is also indicated to increase bone mass in men with primary or hypogonadal osteoporosis who are at high risk for fracture.

Pharmacy needs to define the education, training, regulation, and role of technicians, according to the Sesquicentennial Stepping Stone Summit Two report issued by 14 national groups.